Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2024-03-29 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
关联交易决策制度（2024年3月）
Governance Information Classification · 100% confidence The document is a detailed policy document titled '关联交易决策制度' (Related Party Transaction Decision System) issued by a company. It outlines the principles, definitions, decision-making authority, procedures, and disclosure requirements for related party transactions. It references relevant laws and stock exchange rules, and includes governance and compliance details. There is no financial data, earnings information, or report publication announcement. It is a governance-related internal rules document concerning company operations and compliance with regulatory requirements on related party transactions. Therefore, it fits best under Governance Information (CGR). The document length (6606 characters) and content confirm it is a full policy document, not a brief announcement or certification.
2024-03-29 Chinese
中信证券股份有限公司关于大博医疗科技股份有限公司2024年度继续使用暂时闲置的自有资金进行现金管理的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from CITIC Securities regarding the continued use of temporarily idle funds by Dabao Medical Technology Co., Ltd. for cash management in 2024. It includes descriptions of the purpose, limits, investment types, risk control measures, and approvals from the board, independent directors, and supervisory board. The document is not a financial report but rather a regulatory compliance and verification statement related to the company's cash management activities. It does not contain financial statements or earnings data, nor is it an announcement of a report publication. The document fits best under Regulatory Filings (RNS) as it is a compliance and verification opinion related to regulatory requirements and internal approvals.
2024-03-29 Chinese
2023年度独立董事述职报告（林琳）
Board/Management Information Classification · 95% confidence The document is titled '2023年度独立董事述职报告' which translates to '2023 Annual Independent Director's Work Report'. It details the independent director's activities, attendance at board and shareholder meetings, opinions on various company matters including audit, internal controls, related party transactions, and governance issues during the 2023 fiscal year. The content focuses on the independent director's duties, opinions, and oversight rather than presenting full financial statements or comprehensive financial performance data. It is a detailed management-related report on governance and oversight rather than a full annual report or audit report. Therefore, it fits best under the category of Board/Management Information (MANG), which includes announcements related to board activities and management information. The document length (7242 characters) and detailed content support this classification with high confidence.
2024-03-29 Chinese
中信证券股份有限公司关于大博医疗科技股份有限公司2023年度募集资金年度存放与使用情况的专项核查报告
Audit Report / Information Classification · 95% confidence The document is titled as a "专项核查报告" (special inspection report) regarding the annual deposit and use of raised funds for the year 2023 by a company (大博医疗科技股份有限公司). It is prepared by the sponsor 中信证券股份有限公司. The content details the amount of funds raised, their deposit, usage, management, and compliance with regulatory requirements. It includes tables of fund usage, bank accounts holding the funds, and audit opinions from an accounting firm. The document is a specialized report focused on the management and use of raised capital funds, not a general annual or quarterly financial report. It is not an announcement of a report publication but the report itself, given the length and detailed financial data. This type of document aligns with an Audit Report / Information (AR) category, as it is a standalone audit-related report on the use of raised funds, including verification and compliance with regulations. It is not an Annual Report (10-K), Interim Report (IR), or Capital/Financing Update (CAP) because it focuses specifically on the raised funds usage and audit thereof. Therefore, the best classification is AR with high confidence. FY 2023
2024-03-29 Chinese
董事会审计委员会对2023年度年审会计师履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is titled as a report from the Board Audit Committee regarding the supervision of the annual audit firm for the fiscal year 2023. It discusses the audit firm's qualifications, the process of reappointment, and the committee's evaluation of the audit firm's performance during the 2023 annual audit. The document references the 2023 annual report and related financial statements but does not contain the actual financial statements or detailed financial data itself. It is a standalone report focused on audit supervision and oversight, consistent with an Audit Report / Information filing rather than a full Annual Report or Interim Report. The document length is 1843 characters, which is relatively short and focused on audit committee oversight rather than full financial disclosures. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2023
2024-03-29 Chinese
关于2024年度继续使用暂时闲置的自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company regarding the continued use of temporarily idle funds for cash management through investment in financial products. It includes details about the purpose, amount, investment types, risk control measures, and approvals by the board, independent directors, and supervisory board. The document does not contain financial statements or detailed financial results but is a formal announcement of a financing-related decision and authorization. It is not a full financial report, earnings release, or audit report. It fits best under Capital/Financing Update (CAP) as it relates to the company's capital management and investment activities.
2024-03-29 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.